Provention Bio Inc (PRVB)
15.09
+0.09 +0.60%
NASDAQ
Jun 3, 12:02
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.04 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -44.90M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 720.47M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 10.12 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -9.168M |
| Return on Equity | Upgrade |
View All PRVB News
News
-
WireHeadlineTime (ET)
-
PR Newswire05/28 07:00
-
PR Newswire05/20 07:00
-
PR Newswire05/18 07:00
-
Yahoo05/08 19:30
-
SA Breaking News05/08 11:01
-
PR Newswire05/07 16:05
-
PR Newswire04/30 07:00
-
MT Newswires04/16 11:05
-
SA Breaking News04/16 08:18
-
PR Newswire04/16 07:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/12/2021 | Misc | Provention Bio Inc Fourth Quarter Earnings Conference Call for 2020 |
| 08/06/2020 | Earnings | Provention Bio Inc Second Quarter Earnings Results in 2020 |
| 05/07/2020 16:30 EDT | Misc | Provention Bio Inc First Quarter Earnings Conference Call for 2020 |
| 05/07/2020 | Earnings | Provention Bio Inc First Quarter Earnings Result for 2020 |
| 03/12/2020 08:30 EDT | Misc | Provention Bio Inc Fourth Quarter Earnings Conference Call for 2019 |
| 03/12/2020 | Earnings | Provention Bio Inc Fourth Quarter Earnings in 2019 Release |
| 03/12/2020 | Misc | Provention Bio Inc Annual Report for 2019 |
| 11/05/2019 16:30 EST | Misc | Provention Bio Inc Third Quarter Earnings Conference Call for 2019 |
| 11/05/2019 | Earnings | Provention Bio Inc Third Quarter Earnings Results for 2019 |
| 08/06/2019 | Earnings | Provention Bio Inc Second Quarter Earnings Results in 2019 |
Fundamentals
Income Statement View Statement
Cash Flow Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.proventionbio.com
- Investor Relations URL: N/A
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: Aug. 06, 2020
- Last Earnings Release: May. 07, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 15.09 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PTH | Invesco DWA Healthcare Momentum ETF | 2.00% |
| DWAS | Invesco DWA SmallCap Momentum ETF | 0.95% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRVB Tweets Stocktwits
Advertisement
